{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:10:42Z","timestamp":1779433842153,"version":"3.53.1"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,19]]},"abstract":"<jats:p>\n                    Cardiovascular diseases are popular and contribute to higher morbidity and mortality across the world. Iron deficiency (ID) and anemia are the common complications in the progress of cardiovascular diseases; moreover, ID has the possibility to prevail earlier than the acute attack of the coronary heart diseases. Thus, we tend to verify the prevalence of ID and anemia in relation to coronary artery disease (CAD). We conducted a retrospective study of 313 consecutive adults who underwent invasive coronary angiography for suspected CAD between March 1, 2021 and March 31, 2022. CAD was diagnosed according to European Society of Cardiology guidelines. ID was defined as serum ferritin\u2005&lt;100 \u03bcg\/L, or ferritin 100 to 300 \u03bcg\/L with transferrin saturation\u2005&lt;20%; anemia as hemoglobin\u2005&lt;120 (women) or\u2005&lt;130\u2009g\/L (men). Demographics, vital signs, laboratory indices (including iron parameters, lipids, and estimated glomerular filtration rate), and lifestyle factors were extracted. Group differences (ID vs non-ID) were assessed, and multivariable logistic regression identified factors associated with ID and with CAD presentations. ID and anemia were present in 32% and 33% of patients, respectively. In adjusted models, ID was independently associated with anemia (odds ratio [OR] 4.69, 95% confidence interval [CI] 2.83\u20137.79;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), diabetes (OR 1.92, CI 1.18\u20133.12;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.009), higher heart rate (per 1 bpm: OR 1.02, CI 1.01\u20131.04;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.006), lower estimated glomerular filtration rate (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), and low-density lipoprotein-cholesterol (OR 2.33, CI 1.06\u20135.12;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.036); total cholesterol also differed (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.017). Regarding clinical presentation, ID was associated with unstable angina (adjusted OR 2.47, CI 1.41\u20134.21;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001) and inversely associated with stable angina (OR 0.20, CI 0.07\u20130.62;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.005) and angiographic coronary atherosclerosis (OR 0.44, CI 0.25\u20130.80;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.006). ID and anemia were common among patients with CAD. ID was associated with adverse cardiovascular profiles. Serum iron concentrations were associated with CAD and may serve as a potential predictor, but this requires further validation in prospective studies.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000046494","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T04:02:22Z","timestamp":1766203342000},"page":"e46494","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Iron ion concentrations is related to coronary artery disease: A retrospective study"],"prefix":"10.1097","volume":"104","author":[{"given":"Le","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China"},{"name":"The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhao","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangyu","family":"Liang","sequence":"additional","affiliation":[{"name":"Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Yuan","sequence":"additional","affiliation":[{"name":"Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China"},{"name":"The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ertao","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Guangdong Provincial Second Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China"},{"name":"The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephropathy, Lishui Municipal Central Hospital, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuangxiong","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5645-0885","authenticated-orcid":false,"given":"Jianyong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China"},{"name":"The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260522","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the global burden of disease study 2017.","volume":"392","author":"Roth","year":"2018","journal-title":"Lancet"},{"key":"R2-20260522","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41569-021-00607-3","article-title":"Epidemiology of cardiovascular disease in Europe.","volume":"19","author":"Townsend","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"R3-20260522","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.3390\/nu12103219","article-title":"Ceruloplasmin and coronary heart disease-a systematic review.","volume":"12","author":"Arenas de Larriva","year":"2020","journal-title":"Nutrients"},{"key":"R4-20260522","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1210\/er.2018-00184","article-title":"The forgotten lipids: triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk.","volume":"40","author":"Sandesara","year":"2019","journal-title":"Endocr Rev"},{"key":"R5-20260522","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1474-4422(19)30035-3","article-title":"Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications.","volume":"18","author":"Saba","year":"2019","journal-title":"Lancet Neurol"},{"key":"R6-20260522","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jcmg.2022.03.013","article-title":"Atherosclerotic disease risk stratification using ultrasonographic measurements of plaque.","volume":"15","author":"Nicolaides","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"R7-20260522","doi-asserted-by":"crossref","first-page":"e722","DOI":"10.1161\/CIR.0000000000001040","article-title":"Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association.","volume":"145","author":"Joseph","year":"2022","journal-title":"Circulation"},{"key":"R8-20260522","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12471-017-0959-2","article-title":"Pathophysiology and treatment of atherosclerosis: current view and future perspective on lipoprotein modification treatment.","volume":"25","author":"Bergheanu","year":"2017","journal-title":"Neth Heart J"},{"key":"R9-20260522","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41565-019-0599-3","article-title":"Devouring atherosclerotic plaques.","volume":"15","author":"Fredman","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"R10-20260522","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-physiol-022516-033953","article-title":"Coronary artery development: progenitor cells and differentiation pathways.","volume":"79","author":"Sharma","year":"2017","journal-title":"Annu Rev Physiol"},{"key":"R11-20260522","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/CIRCRESAHA.116.305097","article-title":"Cellular origin and developmental program of coronary angiogenesis.","volume":"116","author":"Tian","year":"2015","journal-title":"Circ Res"},{"key":"R12-20260522","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/CIRCRESAHA.109.209197","article-title":"Epicardial-myocardial signaling directing coronary vasculogenesis.","volume":"106","author":"Olivey","year":"2010","journal-title":"Circ Res"},{"key":"R13-20260522","doi-asserted-by":"crossref","first-page":"108172","DOI":"10.1016\/j.pharmthera.2022.108172","article-title":"Reducing residual cardiovascular risk in Europe: therapeutic implications of European medicines agency approval of icosapent ethyl\/eicosapentaenoic acid.","volume":"237","author":"Chapman","year":"2022","journal-title":"Pharmacol Ther"},{"key":"R14-20260522","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12872-017-0591-5","article-title":"Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.","volume":"17","author":"Halcox","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"R15-20260522","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS guidelines for the management of dyslipidaemias.","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"R16-20260522","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R17-20260522","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1093\/eurheartj\/ehu299","article-title":"Cardiovascular disease in Europe 2014: epidemiological update.","volume":"35","author":"Nichols","year":"2014","journal-title":"Eur Heart J"},{"key":"R18-20260522","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2017.154","article-title":"Epidemiology of cardiovascular disease in young individuals.","volume":"15","author":"Andersson","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"R19-20260522","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00059-020-04935-x","article-title":"ESC 2019 guidelines for the diagnosis and management of chronic coronary syndromes: Recommendations for cardiovascular imaging.","volume":"45","author":"Saraste","year":"2020","journal-title":"Herz"},{"key":"R20-20260522","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.mcna.2016.09.004","article-title":"Iron deficiency anemia.","volume":"101","author":"DeLoughery","year":"2017","journal-title":"Med Clin North Am"},{"key":"R21-20260522","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/ejh.12776","article-title":"Epidemiology of iron deficiency anaemia in four European countries: a population-based study in primary care.","volume":"97","author":"Levi","year":"2016","journal-title":"Eur J Haematol"},{"key":"R22-20260522","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","article-title":"The metabolic underpinnings of ferroptosis.","volume":"32","author":"Zheng","year":"2020","journal-title":"Cell Metab"},{"key":"R23-20260522","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/cdd.2015.158","article-title":"Ferroptosis: process and function.","volume":"23","author":"Xie","year":"2016","journal-title":"Cell Death Differ"},{"key":"R24-20260522","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/joim.13004","article-title":"Iron deficiency anaemia revisited.","volume":"287","author":"Cappellini","year":"2020","journal-title":"J Intern Med"},{"key":"R25-20260522","doi-asserted-by":"crossref","first-page":"e148671","DOI":"10.1172\/JCI148671","article-title":"Ironing out mechanisms of iron homeostasis and disorders of iron deficiency.","volume":"131","author":"Koleini","year":"2021","journal-title":"J Clin Invest"},{"key":"R26-20260522","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/ph11040137","article-title":"Iron regulation: macrophages in control.","volume":"11","author":"Sukhbaatar","year":"2018","journal-title":"Pharmaceuticals (Basel)"},{"key":"R27-20260522","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J"},{"key":"R28-20260522","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nrcardio.2012.122","article-title":"Third universal definition of myocardial infarction.","volume":"9","author":"Thygesen","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"R29-20260522","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/heartjnl-2017-311446","article-title":"Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need.","volume":"104","author":"Ford","year":"2018","journal-title":"Heart"},{"key":"R30-20260522","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrcardio.2015.109","article-title":"Iron deficiency and cardiovascular disease.","volume":"12","author":"von Haehling","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"R32-20260522","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R33-20260522","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/oby.2010.307","article-title":"Association of BMI and cardiovascular risk stratification in the elderly African-American females.","volume":"19","author":"Javed","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"R34-20260522","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"R35-20260522","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: a report from the American Heart Association.","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"R36-20260522","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/eurjpc\/zwab216","article-title":"Role of impaired iron transport on exercise performance in heart failure patients.","volume":"29","author":"Campodonico","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"R37-20260522","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.3390\/jcm11112976","article-title":"Practical guidance for diagnosing and treating iron deficiency in patients with heart failure: why, who and how?","volume":"11","author":"Sindone","year":"2022","journal-title":"J Clin Med"},{"key":"R38-20260522","doi-asserted-by":"crossref","first-page":"892811","DOI":"10.3389\/fendo.2022.892811","article-title":"Association between iron metabolism and acute kidney injury in critically Ill patients with diabetes.","volume":"13","author":"Mo","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R39-20260522","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/nu14020319","article-title":"Decreased iron ion concentrations in the peripheral blood correlate with coronary atherosclerosis.","volume":"14","author":"Meng","year":"2022","journal-title":"Nutrients"},{"key":"R40-20260522","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.cgh.2019.10.017","article-title":"Decreased physical working capacity in adolescents with nonalcoholic fatty liver disease associates with reduced iron availability.","volume":"18","author":"Mitchell","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R41-20260522","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/ehf2.12797","article-title":"Anaemia, iron deficiency and heart failure in 2020: facts and numbers.","volume":"7","author":"Chopra","year":"2020","journal-title":"ESC Heart Fail"},{"key":"R42-20260522","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.","volume":"290","year":"2019","journal-title":"Atherosclerosis"},{"key":"R43-20260522","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"R44-20260522","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R45-20260522","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S2213-8587(22)00043-2","article-title":"Metabolic risk factors and effect of alirocumab on cardiovascular events after acute coronary syndrome: a post-hoc analysis of the ODYSSEY OUTCOMES randomised controlled trial.","volume":"10","author":"Ostadal","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R46-20260522","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC.","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"R47-20260522","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ccell.2022.03.003","article-title":"CD8(+) T cells PUF(A)ing the flames of cancer ferroptotic cell death.","volume":"40","author":"Friedmann Angeli","year":"2022","journal-title":"Cancer Cell"},{"key":"R48-20260522","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3390\/biomedicines9091214","article-title":"Macrophages in atherosclerosis, first or second row players?","volume":"9","author":"Checkouri","year":"2021","journal-title":"Biomedicines"},{"key":"R49-20260522","doi-asserted-by":"crossref","first-page":"1587922","DOI":"10.1155\/2021\/1587922","article-title":"Targeting ferroptosis: pathological mechanism and treatment of ischemia-reperfusion injury.","volume":"2021","author":"Li","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"R50-20260522","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1038\/s41467-020-19193-y","article-title":"Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression.","volume":"11","author":"Yee","year":"2020","journal-title":"Nat Commun"},{"key":"R51-20260522","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/cvr\/cvz084","article-title":"Novel findings in neutrophil biology and their impact on cardiovascular disease.","volume":"115","author":"Bonaventura","year":"2019","journal-title":"Cardiovasc Res"},{"key":"R52-20260522","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/CIRCULATIONAHA.110.961714","article-title":"Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis.","volume":"122","author":"Drechsler","year":"2010","journal-title":"Circulation"},{"key":"R53-20260522","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41569-019-0326-7","article-title":"Neutrophils as regulators of cardiovascular inflammation.","volume":"17","author":"Silvestre-Roig","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"R54-20260522","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.3390\/ijms19061724","article-title":"Role of magnesium deficiency in promoting atherosclerosis, endothelial dysfunction, and arterial stiffening as risk factors for hypertension.","volume":"19","author":"Kostov","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R55-20260522","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nrneph.2015.74","article-title":"Magnesium and cardiovascular complications of chronic kidney disease.","volume":"11","author":"Massy","year":"2015","journal-title":"Nat Rev Nephrol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046494","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:02:54Z","timestamp":1779433374000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":54,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046494","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"2025-08-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}